Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-150
Closed -$8.2K 1223
2020
Q4
$8.2K Hold
150
﹤0.01% 908
2020
Q3
$7.51K Hold
150
﹤0.01% 853
2020
Q2
$5.74K Hold
150
﹤0.01% 856
2020
Q1
$3.28K Hold
150
﹤0.01% 865
2019
Q4
$6.15K Hold
150
﹤0.01% 885
2019
Q3
$6.38K Hold
150
﹤0.01% 864
2019
Q2
$7.4K Hold
150
﹤0.01% 864
2019
Q1
$7.18K Hold
150
﹤0.01% 883
2018
Q4
$9.2K Hold
150
﹤0.01% 806
2018
Q3
$12.4K Hold
150
﹤0.01% 800
2018
Q2
$11.7K Hold
150
﹤0.01% 816
2018
Q1
$11.1K Hold
150
﹤0.01% 815
2017
Q4
$10.2K Buy
+150
New +$9.7K ﹤0.01% 831

Other funds holding NUS

RBC Europe's NUS Position: Q1 2021 in Review

RBC Europe sold out of Nu Skin (NUS) in Q1 2021, closing a stake of 150 shares — an estimated $8.2K sold.

RBC Europe first reported a position in NUS in Q4 2017 and held it in 13 quarters. The position peaked at $12.4K in Q3 2018. 276 funds tracked by Wall St. Rank hold NUS as of Q1 2021.

  • RBC Europe reported no remaining Nu Skin position as of Q1 2021 after selling out during the quarter.
  • RBC Europe sold 150 Nu Skin shares in Q1 2021, an estimated $8.2K.
  • RBC Europe first reported a position in Nu Skin in Q4 2017 and held it in 13 quarters.
  • RBC Europe's Nu Skin position peaked at $12.4K in Q3 2018.
  • 276 funds tracked by Wall St. Rank held Nu Skin as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.